Filing Details

Accession Number:
0000914190-20-000331
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-08-19 18:22:45
Reporting Period:
2020-08-19
Accepted Time:
2020-08-19 18:22:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1196298 Nephros Inc NEPH Surgical & Medical Instruments & Apparatus (3841) 133971809
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1698052 Andrew Astor C/o Nephros, Inc.
380 Lackawanna Place
South Orange NJ 07079
Coo/cfo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2020-08-19 950 $7.40 71,958 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Warrants (right to buy) $2.70 2017-03-17 2022-03-17 14,815 14,815 Direct
Common Stock Stock Option (right to buy) $4.14 2027-02-13 64,399 64,399 Direct
Common Stock Stock Option (right to buy) $2.64 2027-05-01 46,525 46,525 Direct
Common Stock Stock Option (right to buy) $4.50 2027-12-20 5,556 5,556 Direct
Common Stock Stock Option (right to buy) $5.85 2028-12-19 22,223 22,223 Direct
Common Stock Stock Option (right to buy) $8.30 2029-12-16 20,000 20,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2022-03-17 14,815 14,815 Direct
2027-02-13 64,399 64,399 Direct
2027-05-01 46,525 46,525 Direct
2027-12-20 5,556 5,556 Direct
2028-12-19 22,223 22,223 Direct
2029-12-16 20,000 20,000 Direct
Footnotes
  1. On 2/13/17, the Reporting Person was granted an option to purchase 64,399 shares of common stock of the Company. Options to purchase 8,049 shares vested on 2/13/18; options to purchase 24,150 shares vest quarterly in 12 equal amounts commencing on 5/13/18; and options to purchase 32,200 shares vested upon achievement of previously disclosed performance measures.
  2. On 5/1/17, the Reporting Person was granted an option to purchase 46,525 shares of common stock of the Company. Options to purchase 5,815 shares vested on 5/1/18; options to purchase 17,447 shares vest quarterly in 12 equal amounts commencing on 7/1/18; and options to purchase 23,263 shares vested upon achievement of previously disclosed performance measures.
  3. On 12/20/17, the Reporting Person was granted an option to purchase 5,556 shares of common stock of the Company. Options to purchase 1,389 shares vested on 12/20/18 and options to purchase 4,167 shares vest quarterly in 12 equal amounts commencing on 3/20/19.
  4. On 12/19/18, the Reporting Person was granted an option to purchase 22,223 shares of common stock of the Company. Options to purchase 5,555 shares vested on 12/19/19 and options to purchase 16,668 shares vest quarterly in 12 equal amounts commencing on 3/19/20.
  5. On 12/16/19, the Reporting Person was granted an option to purchase 20,000 shares of common stock of the Company. Options to purchase 5,000 shares vest on 12/16/20 and options to purchase 15,000 shares vest quarterly in 12 equal amounts commencing on 3/16/21.